Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - RETAINED EARNINGS
Retained Earnings IKT - Inhibikase Therapeutics, Inc.
-66.9 M
LAST VALUE
-49.79%
2 YEAR CAGR
-59.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR